QTc Time Correlates with Amitriptyline and Venlafaxine Serum Levels in Elderly Psychiatric Inpatients.


Journal

Pharmacopsychiatry
ISSN: 1439-0795
Titre abrégé: Pharmacopsychiatry
Pays: Germany
ID NLM: 8402938

Informations de publication

Date de publication:
Jan 2019
Historique:
pubmed: 22 2 2018
medline: 7 2 2019
entrez: 22 2 2018
Statut: ppublish

Résumé

Many antidepressants cause QT prolongation but the classification of cardiac risk of these drugs varies markedly in different published lists. This retrospective study analyzed the correlation of QTc time with amitriptyline and venlafaxine serum level in elderly psychiatric inpatients. Elderly inpatients aged≥65 years for whom venlafaxine or amitriptyline serum level had been measured were selected retrospectively from a therapeutic drug monitoring database and screened for an electrocardiogram measurement at the time of blood withdrawal. The correlation of amitriptyline or venlafaxine serum levels with QTc time was examined by using Pearson's correlation analysis. Amitriptyline serum levels (n=11) correlated significantly with QTc time (r=0.918, p<0.001, CI 95%). Venlafaxine serum levels (n=27) also correlated significantly with QTc time (r=0.382, p<0.05, CI 95%). Amitriptyline and venlafaxine induce QT prolongation depending on drug concentrations in blood. Its extent, however, is very low when drug serum levels are within the therapeutic range. Future pharmacokinetic studies that correlate drug serum level and QT time should classify the cardiac risk of drugs based on the grade of the regression line in relation to the therapeutic range.

Identifiants

pubmed: 29466824
doi: 10.1055/s-0044-102009
doi:

Substances chimiques

Antidepressive Agents 0
Amitriptyline 1806D8D52K
Venlafaxine Hydrochloride 7D7RX5A8MO

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

38-43

Informations de copyright

© Georg Thieme Verlag KG Stuttgart · New York.

Déclaration de conflit d'intérêts

Christoph Hiemke has received speaker’s and consultancy fees from Janssen, Stada, and Servier. He is managing director of the psiac GmbH (www.psiac.de), which provides an Internet-based drug-drug interaction program. He reports no conflict of interest with this publication. All other authors declare no conflicts of interest as well. The research study did not receive funds or support from any source.

Auteurs

Gudrun Hefner (G)

Psychiatric Hospital, Vitos Klinik Hochtaunus, Friedrichsdorf, Germany.

Martina Hahn (M)

Psychiatric Hospital, Vitos Klinik Eichberg, Eltville, Germany.

Matthias Hohner (M)

Department of Psychiatry and Psychotherapy, University of Würzburg, Würzburg, Germany.

Sybille C Roll (SC)

Psychiatric Hospital, Vitos Klinik Eichberg, Eltville, Germany.

Ansgar Klimke (A)

Psychiatric Hospital, Vitos Klinik Hochtaunus, Friedrichsdorf, Germany.

Christoph Hiemke (C)

Department of Psychiatry and Psychotherapy, University Medical Center of Mainz, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH